MCK Company Profile and Key Details

Q: Who are the executives of MCK?

Ms. Tracy L. FaberExecutive Vice President & Chief HR OfficerMr. Britt J. VitaloneExecutive Vice President & Chief Financial OfficerMr. Napoleon B. Rutledge Jr.Senior Vice President, Controller & Chief Accounting OfficerPaul A. SmithSenior Vice President of TaxesMr. Brian S. Tyler Ph.D.Chief Executive Officer & DirectorMs. Holly WeissSenior Vice President of Investor RelationsMr. Pete SloneSenior Vice President of Corporation Public AffairsMs. Lori A. Schechter J.D.Executive Vice President, Chief Legal Officer & Gen. CounselMs. LeAnn B. SmithExecutive Vice President & Chief HR OfficerMr. Kirk KaminskyPres of The US Pharmaceutical & Specialty Solutions Bus.Ms. Nancy AvilaExecutive Vice President, Chief Information Officer & Chief Technology OfficerRachel RodriguezVice President of Investor Relations

NYSE : MCK

McKesson

$957.80

135.8+16.52%

At Close 4:00 PM

60.65

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

McKesson Corporation (MCK) stock surged +16.52%, trading at $957.80 on NYSE, up from the previous close of $822.00. The stock opened at $862.00, fluctuating between $862.00 and $971.93 in the recent session.

Stock Snapshot

822

Prev. Close

118.22B

Market Cap

862

Day Low

23.7

P/E Ratio

40.42

EPS (TTM)

21.83

Cash Flow per Share

862

Open

123.43M

Number of Shares

971.93

Day High

99.86%

Free Float in %

-15.49

Book Value

2.24M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 05, 2026	862.00	971.93	862.00	957.80	2.22M
Feb 04, 2026	845.00	851.11	817.17	822.00	1.71M
Feb 03, 2026	842.26	855.99	841.04	851.12	796K
Feb 02, 2026	836.09	847.21	830.00	846.51	599.03K
Jan 30, 2026	819.43	833.84	818.70	831.21	692.14K
Jan 29, 2026	830.00	849.05	820.85	822.30	677.66K
Jan 28, 2026	829.36	834.07	815.00	826.62	540.49K
Jan 27, 2026	818.85	843.06	818.85	834.18	563.05K
Jan 26, 2026	822.68	831.38	822.00	826.62	566.59K
Jan 23, 2026	815.25	822.36	810.67	820.23	400.37K
Jan 22, 2026	823.83	826.68	814.99	817.05	583.62K
Jan 21, 2026	819.41	829.07	807.00	823.25	662.54K
Jan 20, 2026	838.42	847.89	820.63	821.84	691.78K
Jan 16, 2026	842.02	847.90	837.64	840.46	585.44K
Jan 15, 2026	832.38	844.26	828.08	844.13	615.23K
Jan 14, 2026	822.79	838.46	820.13	834.16	491.93K
Jan 13, 2026	826.41	836.60	820.03	823.98	486.54K
Jan 12, 2026	817.00	831.32	815.43	825.62	495.07K
Jan 09, 2026	816.98	824.70	814.77	816.06	577.56K
Jan 08, 2026	824.78	838.98	806.10	814.63	684.13K

Contact Details

Irving, TX 75039

United States

https://www.mckesson.com 972 446 4800

About Company

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Stock Peers

COR

22.19+6.72%

Cencora, Inc.$352.16 CAH

20.33+9.83%

Cardinal Health, Inc.$227.18 ABC

-0.41-0.23%

AmerisourceBergen Corporation$179.98 PBH

-1.48-2.21%

Prestige Consumer Healthcare Inc.$65.55 GRDN

1.43+4.55%

Guardian Pharmacy Services, Inc.$32.87 OMI

0.22+8.94%

Owens & Minor, Inc.$2.68 ACH

-0.12-5.17%

Accendra Health, Inc.$2.20

Company Overview

McKesson Corporation (NYSE:MCK) closed at $957.80 USD, gaining $135.80 (16.52%) from the previous close of $822.00. The stock is currently within 5% of its 52-week high $583.55 and $971.93. With a market capitalization of about $118.22 billion, McKesson Corporation is classified as a large-cap and shows lower-than-market volatility (beta ~0.41). Key stats such as the average daily volume over the past year has been around 698.43 thousand shares, trading with heavier-than-usual volume. Headquartered in Irving, TX, McKesson Corporation operates in the Healthcare sector and the Medical - Distribution industry. Led by CEO Brian S. Tyler, the company employs approximately 44,000 people and listed since November 10, 1994. McKesson Corporation provides healthcare services in the United States and internationally.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 14.71%, SMA50 15.34%, SMA200 26.47%). The stock’s 14-day RSI is 76.19 (overbought), while the ATR of 27.8 points to higher daily volatility. The stock remains currently trading near 52-week highs, trading 6.95% below its high and over 67.88% above its low. Average 10-day trading volume of 974.33 thousand shares is slightly above the 3-month average of 697.43 thousand, indicating heightened recent market interest.

Valuation Metrics

McKesson Corporation trades at a P/E ratio of 29.79, slightly below the S&P 500 average, with a price-to-sales ratio of 0.31 and a price-to-book ratio of -69.09 indicating negative book value, which may reflect financial stress. The P/FCF stands at 18.85, also above market averages.

Dividend & Fair Value

McKesson Corporation last paid a dividend of 3.28 per share, this equals a trailing yield of roughly 0.45%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.39 thousand. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

McKesson Corporation generated EPS of $34.77 over the past year. Five-year average earnings growth is 39.07%. Wall Street analysts project EPS growth of 14.78% annually over the next five years. The latest quarter delivered EPS of $9.86. The next quarter is forecast at $11.41. Next year's EPS is expected at $12.48. Analyst sentiment is bullish. Analyst rating data shows there are 11 Strong Buy ratings, 9 Buy ratings, 8 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $1.01 thousand to $675.00. The high target offers 5.66% upside. The low target suggests -29.53% downside. The mean target is $846.00. This offers -11.67% upside. McKesson Corporation earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 05, 2025, missed forecasts by 9.19%. The prior quarter beat by 1.47%. Over the last six quarters, Apple has recorded several small beats. These include 9.29% in August 07, 2024.

Shareholding & Insider Activity

McKesson Corporation has 124.38 million shares outstanding. The public float is 124.21 million shares, elevated short interest at 1.51% of float. This equals 1.88 million shares. The short ratio is 2.31 days. Institutional investors hold 90.69% of the float. Insiders own 0.03%. Vitalone Britt J. holds 14.03 thousand shares, Flores Nancy has 4.73 thousand shares and Avila Nancy has 4.63 thousand shares. Over the past six months, insider transactions show net selling. They sold 24.79 thousand shares across 5 transactions.

Financial & Profitability Overview

Over the trailing twelve months, McKesson generated $359.05B in revenue, or $2.80K per share. Gross margin was 3.48%, operating margin 1.22%, and net profit margin 0.92%. Returns are negative, with ROA at 4.39% and ROE at -158.87%.
On valuation metrics, McKesson trades at a P/E of 29.79, P/S of 0.31 and P/B of -69.09. Liquidity is tight, with a current ratio of 0.88 and quick ratio of 0.50. Operationally, the company’s inventory turnover is 14.32 and cash conversion cycle is -7.28 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is -5.63, supported by a cash flow-to-debt ratio of 0.70.

Quarterly Financial Highlights

For the quarter ended Mar 31, 2025, McKesson posted revenue of $359.05B, down slightly from $308.95B in the prior quarter. Gross profit was $12.49B (margin 3.48%). Operating income was $4.37B (margin 1.2%). Net income was$3.30B (EPS $25.86).
The company ended the quarter with $5.69B in cash and short-term investments, a total debt of $7.39B, and net debt of $1.70B. Total assets were $75.14B, with equity of - $1.69B. Financials further reflected stability, with operating cash flow of $6.09B, free cash flow of $5.23B, and capital expenditures of - $859.00M.

Price Forecast & Outlook

Our AI price prediction model suggests that McKesson Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -5.56%, with price expected at $904.50 by February 19, 2026, within a range of $882.25 to $925.82 3-Month Outlook: Projected rise of 15.97%, reaching $1.11 thousand by May 06, 2026, with a range of $1.09 thousand to $1.13 thousand. 1-Year Outlook: Projected gain of 9.94%, with price at $1.05 thousand by February 05, 2027, within a range of $1.04 thousand to $1.07 thousand.

Key Takeaways

McKesson Corporation (NYSE:MCK) shares are flat 0.19% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows McKesson Corporation trading at a premium to the broader market with a P/E of 29.79. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $604.01, suggesting -36.94% downside. Our AI forecast model points to short-term weakness (-5.56% over two weeks), a medium-term rise (15.97% over three months), and a longer-term gain (9.94% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current McKesson Corporation (MCK) stock price?

McKesson Corporation (NYSE: MCK) stock price is $957.80 in the last trading session. During the trading session, MCK stock reached the peak price of $971.93 while $862.00 was the lowest point it dropped to. The percentage change in MCK stock occurred in the recent session was 16.52% while the dollar amount for the price change in MCK stock was $135.80.

MCK's industry and sector of operation?

The NYSE listed MCK is part of Medical - Distribution industry that operates in the broader Healthcare sector. McKesson Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MCK?

Ms. Tracy L. Faber
Executive Vice President & Chief HR Officer
Mr. Britt J. Vitalone
Executive Vice President & Chief Financial Officer
Mr. Napoleon B. Rutledge Jr.
Senior Vice President, Controller & Chief Accounting Officer
Paul A. Smith
Senior Vice President of Taxes
Mr. Brian S. Tyler Ph.D.
Chief Executive Officer & Director
Ms. Holly Weiss
Senior Vice President of Investor Relations
Mr. Pete Slone
Senior Vice President of Corporation Public Affairs
Ms. Lori A. Schechter J.D.
Executive Vice President, Chief Legal Officer & Gen. Counsel
Ms. LeAnn B. Smith
Executive Vice President & Chief HR Officer
Mr. Kirk Kaminsky
Pres of The US Pharmaceutical & Specialty Solutions Bus.
Ms. Nancy Avila
Executive Vice President, Chief Information Officer & Chief Technology Officer
Rachel Rodriguez
Vice President of Investor Relations

How MCK did perform over past 52-week?

MCK's closing price is 67.89% higher than its 52-week low of $583.55 where as its distance from 52-week high of $971.93 is -1.45%.

How many employees does MCK have?

Number of MCK employees currently stands at 44,000.

Link for MCK official website?

Official Website of MCK is: https://www.mckesson.com

How do I contact MCK?

MCK could be contacted at phone 972 446 4800 and can also be accessed through its website. MCK operates from 6555 State Highway 161, Irving, TX 75039, United States.

How many shares of MCK are traded daily?

MCK stock volume for the day was 2.24M shares. The average number of MCK shares traded daily for last 3 months was 698.43K.

What is the market cap of MCK currently?

The market value of MCK currently stands at $118.22B with its latest stock price at $957.80 and 123.43M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	44000
Beta	0.41
Sales or Revenue	$359.05B
5Y Sales Change%	1.208%
Fiscal Year Ends	March
Sector	Healthcare
Industry	Medical - Distribution

MCK Company Profile and Key Details

McKesson

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook